<DOC>
	<DOCNO>NCT00163254</DOCNO>
	<brief_summary>The Below-Study randomized , prospective mono-centre trial efficacy safety adjunctive use GP IIb/IIIa antagonist prevention early reocclusion arterial below-the knee intervention .</brief_summary>
	<brief_title>Below Study - Balloonangioplasty Stents With ReoPro Prevention Subacute Reocclusion Arteries Below Knee</brief_title>
	<detailed_description>PTA knee limit due subacute reocclusions uncertain long-term result . This study design feasibility trial , compare two new treatment modality : drug elute stent GP IIb/IIIa blockade . Patients current ulcer ( Rutherford 5 , 6 ) randomly assign one treatment group : [ 1 ] ReoPro + Sirolimus coat stent , [ 2 ] ReoPro + bare Stent , [ 3 ] ReoPro + PTA , [ 4 ] PTA without ReoPro . Angiographic control 2 6 month block wise randomisation treatment group .</detailed_description>
	<mesh_term>Abciximab</mesh_term>
	<criteria>Patients history peripheral artery disease knee artery occlusion , stenosis mandate PTA stent administration first treatment modality . The history peripheral artery occlusion least 6 week , target vessel occlusion longer 5 centimeter length ( correspond maximum 2 stent per treat lesion ) . The number treat lesion per vessel study limit three . Only major lesion allocate one study group , lesion treat conventional PTA . A documentation distal outflow ( occlusion 3 cm upper joint ankle ) mandatory Severe stage PAD ulceration ( ) correspond Rutherford stage 5 6 . Acute limb ischemia Subacute ischemia require thrombolysis first treatment modality Active bleeding know bleeding diathesis Known severe hepatic renal disorder ( liver cirrhosis , stage B , C serum creatinine &gt; 2.5 mg % ) Hyperthyreosis Diabetes mellitus treat metformin Known heparin induce thrombocytopenia ( HIT , type 2 ) Major surgery , eye surgery trauma within past 6 week History stroke within previous 2 year , stroke residual neurological deficit , CNS abnormality ( e.g. , intracranial neoplasm , arteriovenous malformation , aneurysm ) , history aneurysm repair Gastrointestinal genitourinary bleed clinical significance within previous 6 week Puncture non compressible vessel within past 24 hour Administration oral anticoagulant within previous 7 day unless prothrombin time &lt; 1.2 time control ( international normalize ratio [ INR ] &lt; 1.4 ) , ongoing treatment oral anticoagulant History bleed diathesis platelet count &lt; 100,000/mm3 Known ReoProinduced thrombocytopenia Arteriovenous malformation aneurysms Severe uncontrolled hypertension ( treat sys . BP &gt; 200 mm Hg , diast . BP &gt; 100 mm Hg ) Known autoimmune disorder Patient vasculitis Patient aspirin intolerance Contraindication know allergic reaction rapamycin , abciximab murine protein Coexistent condition associate limited life expectancy ( e.g. , advanced cancer , endstage congestive heart failure ) Women childbearing potential positive pregnancy test Patient prison vulnerable patient ( soldier , â€¦ ) define declaration Helsinki</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Chronic limb ischemia</keyword>
	<keyword>Intervention</keyword>
	<keyword>Restenosis</keyword>
	<keyword>Patients 18 year</keyword>
</DOC>